Pharma group extends K+N contract

LinkedIn +

Pharmaceutical group Merck Sharp & Dohme has extended its overland contract with Kuehne + Nagel in Europe, Middle East, Africa and North America for another two years.

It has used the KN PharmaChain since 2012. Kuehne + Nagel will continue to manage GXP certified FTL and LTL temperature-controlled services for pharmaceutical products across the EMEA region and within North America.

In addition Kuehne + Nagel manages transport of palletised pharmaceuticals from MSD’s manufacturing sites in Europe and North America to its global distribution centres, where products are managed and controlled by a dedicated team of Kuehne + Nagel pharma specialist in an environment specially designed to meet the GXP guidelines.

Frederic Brut, MSD executive director global logistics, said: “Kuehne + Nagel has proven to be a reliable partner that is able to meet our challenging requirements thanks to its expertise in the pharma and healthcare industry. We are confident that our collaboration will support our growth ambitions over the next years.”

Share this story: